Robuta

https://growthmarketreports.com/report/bacteria-specific-endolysin-topical-acne-gel-market Bacteria-Specific Endolysin Topical Acne Gel Market Research Report 2033 According to our latest research, the global bacteria-specific endolysin topical acne gel market size reached USD 243.8 million in 2024, demonstrating robust... market research reportacne gelbacteriaspecifictopical https://spaed.ca/ SPAED | Phage endolysin domain segmentation A tool for segmenting phage endolysin domains. phagedomainsegmentation https://pubmed.ncbi.nlm.nih.gov/37523902/ Characterization of the Clostridium perfringens phage endolysin cpp-lys and its application on... Clostridium perfringens is an important foodborne pathogen that can have severe consequences, including mortality and economic losses. In this study, the gene... https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2017.00293/full Frontiers | A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa The global increase in multidrug-resistant (MDR) bacteria has led to phage therapy being refocused upon. A novel endolysin, LysPA26, containing a lysozyme-li... a novelfrontiersantimicrobialpseudomonas https://www.prnewswire.com/nl/persberichten/micreos-initiates-clinical-trial-to-evaluate-world-s-first-endolysin-drug-as-a-therapy-for-atopic-dermatitis-843691493.html Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic... /PRNewswire/ -- Dutch biotech company Micreos Human Health has enrolled the first patients in a Phase I/IIa, randomized, double-blind, placebo-controlled,...